CClinicalTrials.gg
CompletedNCT05033509Updated Sep 2, 2021

Outcome of ECMO and CRRT.

An observational study in Incidence of CRRT With ECMO Therapy, Mortality and and Renal Recovery, sponsored by Mohammed VI University Hospital. Completed at 1 site in Morocco. Per ClinicalTrials.gov, last updated 2021-09-02.

Sponsored by Mohammed VI University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
30
Sex
All
01

Study summary

Background:

Although acute kidney injury (AKI) is a frequent complication in patients receiving extracorporeal membrane oxygenation (ECMO), and the CRRT impact is widely studied. The incidence of simultaneous use of ECMO and CRRT remain unclear.

Objective: The investigatore conducted this retrospective study to define the incidence of concomitant CRRT with ECMO therapy and to determine the overall impact of this strategy on patient outcomes such as mortality and renal recovery.

Methods:

The investigatore retrospectively analyzed data of patients of all ages, genders and ethnicities, admitted in the intensive care unit of Mohammed VI University Hospital, Oujda, Morocco, on a cumulative period of 2 years (January 2019 - December 2020). Were enrolled in the study patients who benefited from ECMO, and presented an acute kidney injury afterwards, using 'Microsoft Excel' as a software to utilize the information collected from the computerized patient database. 30 patients were included in the final study.

02

Conditions studied

  • Incidence of CRRT With ECMO Therapy
  • Mortality
  • and Renal Recovery

Keywords

  • COVID
  • AKI
  • CRRT
  • Ecmo
03

In context

Lead sponsor

Mohammed VI University Hospital is the lead sponsor of 11 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We retrospectively analyzed data of patients of all ages, genders and ethnicities, admitted in the intensive care unit of Mohammed VI University Hospital, Oujda, Morocco, on a cumulative period of 2 years

Inclusion criteria

  • benefited from ECMO .
  • presented an acute kidney injury afterwards

Exclusion criteria

Exclusion Criteria:

  • patients who developed AKI before benefitting from ECMO and/or missing data
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
30 participants (actual)
Patient registry
No

Groups and cohorts

  • ECMO and AKI

    Other: supervision the Kidney fonction on ECMO

Interventions

  • Othersupervision the Kidney fonction on ECMO

    patients who benefited from ECMO, and presented an acute kidney injury afterwards

06

What researchers measure

Primary outcomes

  1. Ecmo and severe AKI requiring CRRT

    2 groups of patient was identified on this study : first ones are how developped aki and needek CRRT , 2nd are those who developped aki without CRRT

    Time frame: through study completion, an average of 24 mounths

07

Study locations

1 site
  • younes Oujidi
    Berkane, 9999, Morocco
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05033509
Lead sponsor
Mohammed VI University Hospital
Responsible party
Younes Oujidi (Principal Investigator, Mohammed VI University Hospital) — Principal investigator
First posted
Sep 2, 2021
Start date
Jan 1, 2019
Primary completion
Dec 31, 2020
Completion
Dec 31, 2020
Last update
Sep 2, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion